Growth Metrics

Cytosorbents (CTSO) Current Deferred Revenue (2013 - 2026)

Cytosorbents posted quarterly Current Deferred Revenue of $34000.0 for Q1 2026, down 93.77% year-on-year from $546028.0 in Q1 2025, and down 81.32% on a QoQ basis from $182000.0 in Q4 2025.

Cytosorbents (CTSO) has 9 years of Current Deferred Revenue data on file, last reported at $34000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Deferred Revenue fell 93.77% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $34000.0 (down 93.77% YoY), and the FY2025 full-year result was $182000.0, down 69.46% from the prior year.
  • Current Deferred Revenue for Q1 2026 stood at $34000.0, down from $182000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.5 million in Q4 2022 and bottomed at $34000.0 in Q1 2026.
  • The 5-year median for Current Deferred Revenue is $474514.0 (2025), against an average of $627452.6.
  • The widest annual swing landed in 2023, when Current Deferred Revenue fell 8.96%; it then sank 93.77% in 2026.
  • A 5-year view of Current Deferred Revenue shows it stood at $1.5 million in 2022, then declined by 8.96% to $1.4 million in 2023, then sank by 56.84% to $596000.0 in 2024, then tumbled by 69.46% to $182000.0 in 2025, then slumped by 81.32% to $34000.0 in 2026.
  • The last three Current Deferred Revenue figures came in at $34000.0 (Q1 2026), $182000.0 (Q4 2025), and $403000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 34,000.00
Dec 31, 2025 182,000.00
Sep 30, 2025 403,000.00
Jun 30, 2025 361,000.00
Mar 31, 2025 546,028.00
Dec 31, 2024 596,000.00
Dec 31, 2023 1.38 Mn
Dec 31, 2022 1.52 Mn
Dec 31, 2021 1.95 Mn
Dec 31, 2020 728,351.00
Dec 31, 2014 833.00
Sep 30, 2014 3,333.00
Jun 30, 2014 5,833.00
Mar 31, 2014 117,364.00
Dec 31, 2013 272,359.00
Sep 30, 2013 435,686.00